Fallopian tube cancer Trials in Houston, United States
Conditions / Fallopian tube cancer / Houston, United States
Research into Fallopian tube cancer spans multiple therapeutic approaches and trial phases.
54 total trials for this combination
Showing top 10 of 54 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02433626 | Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies | UNKNOWN | PHASE1 |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study | RECRUITING | PHASE1/PHASE2 |
| NCT03038100 | A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | COMPLETED | PHASE3 |
| NCT01493505 | TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer | TERMINATED | PHASE3 |
| NCT03329950 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | COMPLETED | PHASE1 |
| NCT05377996 | A Study of XMT-1660 in Participants With Solid Tumors | RECRUITING | — |
| NCT04442126 | A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors | TERMINATED | PHASE1/PHASE2 |
| NCT05179824 | Tempus Priority Study: A Pan-tumor Observational Study | ACTIVE_NOT_RECRUITING | — |
| NCT03849469 | A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT05274451 | A Study to Investigate LYL797 in Adults With Solid Tumors | TERMINATED | PHASE1 |